Drug intelligence / Profile preview

Lactibiane ATB

Development stage: Unknown
Lead developer: PiLeJe
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactibiane ATB is a probiotic dietary supplement developed by the French laboratory PiLeJe. It is specifically formulated to support and protect the intestinal microbiota during and after antibiotic treatment. The primary active component is the probiotic strain *Lactobacillus rhamnosus* LA801 (also classified as *Lacticaseibacillus rhamnosus*), provided at a concentration of 12 billion CFU per capsule. By replenishing beneficial bacteria, Lactibiane ATB aims to prevent antibiotic-associated dysbiosis and reduce the incidence of gastrointestinal side effects such as antibiotic-associated diarrhea (AAD).

Brand names: Lactibiane ATB

Beyond the preview

Go deeper on Lactibiane ATB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactibiane ATB.

Explore the full profile